Gilead(GILD) - 2025 FY - Earnings Call Transcript

Gilead Sciences (NasdaqGS:GILD) FY 2025 Conference December 02, 2025 11:15 AM ET Speaker0Used in about 45% of HIV prevention patients today. It's a once-daily pill with two medicines. The daily orals work really well. The challenge is that people that don't have HIV do not take the pills on a daily basis, so you don't get the benefit that you would get if people stayed on the pills every day. It's really challenging. The adherence is very low for the daily pills. That's where you see an incredible differenc ...